Recombinant Shingles Vaccine

Recombinant Shingles Vaccine Linked to Reduced Cardiovascular Risk

This entry was posted in Cardiovascular Diseases and tagged CVD Recombinant Shingles Vaccine Risk on

The recombinant shingles vaccine was associated with a 9% reduction in overall cardiovascular burden over 7 years among adults aged 60 years or older, based on a natural experiment that reduced confounding from existing studies comparing vaccinated and unvaccinated individuals. Researchers compared adults vaccinated immediately before versus immediately after the […]

Recombinant Shingles Vaccine Linked to Lower Dementia Risk

This entry was posted in Mental Disorders and tagged Dementia Recombinant Shingles Vaccine Risk on

A U.S. study found that receiving the recombinant herpes zoster vaccine (RZV, shingles vaccine) was associated with a significantly lower risk of developing dementia among older adults admitted to skilled-nursing facilities. Researchers analyzed data from 509,926 Medicare beneficiaries aged 66 years or older who had no prior dementia diagnosis and […]